First-in-class SAM-competitive G9a inhibitor FLAV-27 as a disease-modifying therapy for Alzheimer disease.
首个SAM竞争性G9a抑制剂FLAV-27作为阿尔茨海默病疾病修饰疗法。
期刊:Molecular Therapy
影响因子:12
doi:10.1016/j.ymthe.2025.12.038
Bellver-Sanchis Aina, Valle-Garcia David, Barbaraci Carla, Romero-Becerra Fernando, Singh Rohit Kumar, Jarne-Ferrer Júlia, Vasilopoulou Foteini, Irisarri Alba, MartÃnez-Fernández Carmen, Fafián-Labora Juan A, Arufe MarÃa C, Wüst Carolin, Castellanos Aida, Soto David, Casals Núria, Fadó Rut, Pocock Jennifer M, Navarro Gemma, Val Cristina, Brea José, Loza M Isabel, Lleó Albert, Fortea Juan, Alcolea Daniel, Perez-Bosque Anna, Miró Lluïsa, Pérez Belén, Rashid Sajid, Ali Muhammad, Saqib Manahil, Là Carbó Marcel, Guerrero Ana, Vázquez Santiago, Choudhary Bhanwar Singh, Dai Shaodong, Escolano Carmen, Franco Rafael, Pallà s Mercè, Griñán-Ferré Christian